3 unknown, 1 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 3, Completed 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow molgramostim: new trials by email Literature Review of molgramostim trials Research Report on molgramostim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy - Malignant Ascites | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital of Soochow University | 40 | 2022-09-01 | 2022-08-15 |
| Effect of rhGM-CSF on the Healing of Venous Leg Ulcers rhGM-CSF + hydrogel, Placebo hydrogel, Standard care - Venous Leg Ulcer | Phase 2 | Unknown | Reponex Pharmaceuticals A/S | 6 | 2021-03-11 | 2022-11-17 |
| Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis Molgramostim, Placebo, PARI eFlow nebulizer system - Autoimmune Pulmonary Alveolar Proteinosis | Phase 2 | Completed | Savara Inc. | 139 | 2016-03-21 | 2023-04-12 |
| Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients CSF470 vaccine, BCG, Molgramostim, interferon alpha 2b - Cutaneous Melanoma | Phase 2 / Phase 3 | Unknown | Laboratorio Pablo Cassara S.R.L. | 108 | 2009-04-01 | 2015-09-02 |
Melanoma (1) · Pulmonary Alveolar Proteinosis, Acquired (1) · Varicose Ulcer (1)
Laboratorio Pablo Cassara S.R.L. (1) · Reponex Pharmaceuticals A/S (1) · Savara Inc. (1) · Second Affiliated Hospital of Soochow University (1)
Denmark (2) · Argentina (1) · Australia (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Portugal (1) · Russia (1) · Slovakia (1) · South Korea (1) · Spain (1)
Cliff Morgan, MD (1) · Ewa A Burian, MD (1)
2015 (1)